JG
Joana Goncalves (Chief Medical Officer) filed 10 Form 4 reports in the trailing twelve months (0 purchases, 10 sales), most often in Oruka Therapeutics, Inc. (ORKA). The largest single filing was $651K of ORKA (5,800 sh across 2 lots, as filed), executed Aug 17. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
10
0 buys · 10 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$4.2M
shares × price, as filed
Last traded
Oct 15
Filed Oct 15
Median ADV $139.8M across their filed names
Open performance→Volume by month
Buys $0
Sells $4.2M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
10 filings
Sector per market data · by filing · past 12 months
Most traded names
ORKARecent filings
ORKASALE
Oruka Therapeutics, Inc.
View filing →
$454K6,100 sh across 3 lots
Exec Oct 15
Filed Oct 15 · 6:15 PM ET ORKASALE Oruka Therapeutics, Inc. View filing → $634K
6,900 sh across 3 lots
Exec Sep 15
Filed Sep 15 · 7:18 PM ET ORKASALE Oruka Therapeutics, Inc. View filing → $651K
5,800 sh across 2 lots
Exec Aug 17
Filed Aug 17 · 6:09 PM ET ORKASALE Oruka Therapeutics, Inc. View filing → $544K
6,300 sh across 2 lots
Exec Jul 15
Filed Jul 15 · 7:36 PM ET ORKASALE Oruka Therapeutics, Inc. View filing → $463K
6,700 sh across 2 lots
Exec Jun 15
Filed Jun 15 · 5:30 PM ET ORKASALE Oruka Therapeutics, Inc. View filing → $427K
6,900 sh across 2 lots
Exec May 15
Filed May 15 · 5:30 PM ET ORKASALE Oruka Therapeutics, Inc. View filing → $429K
6,500 sh across 2 lots
Exec Apr 15
Filed Apr 15 · 5:30 PM ET ORKASALE Oruka Therapeutics, Inc. View filing → $237K
5,823 sh across 2 lots
Exec Mar 16
Filed Mar 17 · 5:30 PM ET More filings →